The direct involvement of PCSK9 in lipid metabolism was originally observed when documenting the gain of function mutation of the PCSK9 gene, lowering the LDLR in the liver, which, in turn, translates to high levels of circulating LDL-C and increased susceptibility to coronary heart disease [6]. The gene discussed is PCSK9; the disease is coronary artery disorder.